US FDA approves expanded use of Amgen’s psoriasis drug
The drug is already approved for three indications, including to treat patients with moderate-to-severe plaque psoriasis and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
otezla
Amgen announces positive top-line results from Otezla phase-III Discreet study in moderate-to-severe…
Otezla resulted in clinically and statistically significant improvements in measures of genital psoriasis at week 16 compared with…
AbbVie, Amgen and Takeda jointly study impact of anti-inflammatory drugs in COVID-19 treatment
I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…